Milan Justyna, Niemczyk Klaudia, Kus-Liśkiewicz Małgorzata
Institute of Biology and Biotechnology, College of Natural Sciences, University of Rzeszow, St. Pigonia 1, 35-310 Rzeszow, Poland.
Materials (Basel). 2022 May 7;15(9):3355. doi: 10.3390/ma15093355.
Recent advances in the synthesis of metal nanoparticles (NPs) have led to tremendous expansion of their potential applications in different fields, ranging from healthcare research to microelectronics and food packaging. Among the approaches for exploiting nanotechnology in medicine, gold nanomaterials in particular have been found as the most promising due to their unique advantages, such as in sensing, image enhancement, and as delivery agents. Although, the first scientific article on gold nanoparticles was presented in 1857 by Faraday, during the last few years, the progress in manufacturing these nanomaterials has taken an enormous step forward. Due to the nanoscale counterparts of gold, which exhibit distinct properties and functionality compared to bulk material, gold nanoparticles stand out, in particular, in therapy, imaging, detection, diagnostics, and precise drug delivery. This review summarizes the current state-of-the-art knowledge in terms of biomedical applications of gold nanoparticles. The application of AuNPs in the following aspects are discussed: (i) imaging and diagnosing of specific target; (ii) treatment and therapies using AuNPs; and (iii) drug delivery systems with gold nanomaterials as a carrier. Among the different approaches in medical imaging, here we either consider AuNPs as a contrast agent in computed tomography (CT), or as a particle used in optical imaging, instead of fluorophores. Moreover, their nontoxic feature, compared to the gadolinium-based contrast agents used in magnetic resonance imaging, are shown. The tunable size, shape, and functionality of gold nanoparticles make them great carriers for targeted delivery. Therefore, here, we summarize gold-based nanodrugs that are FDA approved. Finally, various approaches to treat the specific diseases using AuNPs are discussed, i.e., photothermal or photodynamic therapy, and immunotherapy.
金属纳米颗粒(NPs)合成技术的最新进展极大地拓展了其在不同领域的潜在应用范围,涵盖了从医疗保健研究到微电子和食品包装等领域。在医学领域利用纳米技术的诸多方法中,金纳米材料因其独特优势,如传感、图像增强及作为递送载体等,被认为是最具潜力的。尽管法拉第在1857年发表了首篇关于金纳米颗粒的科学文章,但在过去几年里,这些纳米材料的制造取得了巨大进展。由于金的纳米级对应物与块状材料相比具有独特的性质和功能,金纳米颗粒在治疗、成像、检测、诊断及精确药物递送等方面表现突出。本综述总结了金纳米颗粒生物医学应用方面的当前前沿知识。讨论了金纳米颗粒在以下方面的应用:(i)特定靶点的成像与诊断;(ii)使用金纳米颗粒的治疗方法;(iii)以金纳米材料为载体的药物递送系统。在医学成像的不同方法中,我们在此将金纳米颗粒视为计算机断层扫描(CT)中的造影剂,或光学成像中使用的粒子,而非荧光团。此外,还展示了与磁共振成像中使用的钆基造影剂相比,它们的无毒特性。金纳米颗粒可调节的尺寸、形状和功能使其成为靶向递送的理想载体。因此,我们在此总结了已获美国食品药品监督管理局(FDA)批准的金基纳米药物。最后,讨论了使用金纳米颗粒治疗特定疾病的各种方法,即光热或光动力疗法以及免疫疗法。